| |
| |
|
| Insider
Information: |
Mallon Mark |
| Relationship: |
Chief Executive Office... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
838,656 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,884,372 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
838,656 |
|
|
| Total
Value |
$8,884,372 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -66.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
Chief Executive Office... |
2021-02-26 |
470,605 |
2019-01-09 |
0 |
Premium* |
|
|
NeoGenomics Inc |
NEO |
Chief Executive Office... |
2022-03-01 |
368,051 |
2021-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEO |
NeoGenomics Inc |
Chief Executive Officer |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
142,457 |
368,051 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Chief Executive Officer |
• • – |
2021-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
152,858 |
225,594 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Chief Executive Officer |
• • – |
2021-12-06 |
4 |
B |
$30.63 |
$520,710 |
D/D |
17,000 |
72,736 |
2.81 |
% |
|
| NEO |
NeoGenomics Inc |
Chief Executive Officer |
• • – |
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,736 |
55,736 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-02-26 |
4 |
AS |
$9.11 |
$279,449 |
D/D |
(30,675) |
470,605 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-05-11 |
4 |
AS |
$10.35 |
$240,182 |
D/D |
(23,206) |
501,280 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
221,061 |
524,486 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-02-24 |
4 |
AS |
$11.25 |
$11 |
D/D |
(1) |
303,425 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2020-02-21 |
4 |
AS |
$11.63 |
$92,842 |
D/D |
(7,983) |
303,426 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
218,373 |
311,409 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Executive Senior Advisor |
• – – |
2019-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
93,036 |
93,036 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
